Paraoxonase 1 and atherosclerosis-related diseases

被引:61
作者
Kotur-Stevuljevic, Jelena [1 ]
Vekic, Jelena [1 ]
Stefanovic, Aleksandra [1 ]
Zeljkovic, Aleksandra [1 ]
Ninic, Ana [1 ]
Ivanisevic, Jasmina [1 ]
Miljkovic, Milica [1 ]
Sopic, Miron [1 ]
Munjas, Jelena [1 ]
Mihajlovic, Marija [1 ]
Spasic, Slavica [1 ]
Jelic-Ivanovic, Zorana [1 ]
Spasojevic-Kalimanovska, Vesna [1 ]
机构
[1] Univ Belgrade, Fac Pharm, Dept Med Biochem, POB 146, Belgrade 11000, Serbia
关键词
atherosclerosis; cancer; cardiovascular disease; diabetes; HDL dysfunction; paraoxonase; 1; renal disease; stroke; HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; APOLIPOPROTEIN-A-I; OBSTRUCTIVE PULMONARY-DISEASE; HDL PARTICLE-SIZE; OXIDATIVE STRESS; DIABETES-MELLITUS; PON1; ACTIVITY; HEART-DISEASE; CARDIOVASCULAR-DISEASE;
D O I
10.1002/biof.1549
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A direct and an indirect relationship between paraoxonase 1 (PON1) and atherosclerosis exists. Given PON1's physical location within high-density lipoprotein (HDL) particles and its recognized enzyme activity, it is certainly reasonable to suggest that PON1 facilitates the antiatherogenic nature of HDL particles. PON1 also plays a role in regulating reverse cholesterol transport, antioxidative, anti-inflammatory, antiapoptotic, vasodilative, and antithrombotic activities and several endothelial cell functions. HDL dysfunctionality is a more recent issue and seems to be centered on pathological conditions affecting HDL structure and size profiles. This review is focused on the role of PON1 status in different atherosclerosis-related diseases that we have studied over the last twenty years (coronary heart disease, acute ischemic stroke, diabetes mellitus type 2, end-stage renal disease, chronic obstructive pulmonary disease, and sarcoidosis) with the aim to determine the true value of PON1 as a biomarker. The role of PON1 in cancer is also covered, as risk factors and mechanisms underlying both atherosclerosis and cancer share common features.
引用
收藏
页码:193 / 205
页数:13
相关论文
共 139 条
[1]   SERUM PARAOXONASE ACTIVITY, CONCENTRATION, AND PHENOTYPE DISTRIBUTION IN DIABETES-MELLITUS AND ITS RELATIONSHIP TO SERUM-LIPIDS AND LIPOPROTEINS [J].
ABBOTT, CA ;
MACKNESS, MI ;
KUMAR, S ;
BOULTON, AJ ;
DURRINGTON, PN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1812-1818
[2]   Association between Q192R polymorphism in the PON1 gene and statin responses in cardiac patients [J].
Abd Elgwad, Eman R. ;
Behiry, Eman G. ;
Swailem, Fathy M. ;
Ameen, Seham G. ;
Abdelhasib, Dalia M. ;
Abd Elhamid, Rabab O. .
ANNALS OF MEDICINE AND SURGERY, 2018, 31 :1-5
[3]  
Abou-Raya A, 2018, CARDIOVASCULAR GENET, P679
[4]   Paraoxonase-1 activity in patients with cancer: A systematic review and meta-analysis [J].
Arenas, M. ;
Rodriguez, E. ;
Sahebkar, A. ;
Sabater, S. ;
Rizo, D. ;
Pallise, O. ;
Hernandez, M. ;
Riu, F. ;
Camps, J. ;
Joven, J. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 127 :6-14
[5]  
AVIRAM M, 2012, J LIPIDS, V2012, DOI DOI 10.1155/2012/687273
[6]   Increased Risk of Atherosclerosis in Patients with Sarcoidosis [J].
Bargagli, Elena ;
Rosi, Elisabetta ;
Pistolesi, Massimo ;
Lavorini, Federico ;
Voltolini, Luca ;
Rottoli, Paola .
PATHOBIOLOGY, 2017, 84 (05) :258-263
[7]  
Beltowski J, 2002, POL J PHARMACOL, V54, P661
[8]   Circulating transforming growth factor-β1, lipoprotein(a) and cellular adhesion molecules in angiographically assessed coronary artery disease [J].
Bogavac-Stanojevic, N ;
Djurovic, S ;
Jelic-Ivanovic, Z ;
Spasojevic-Kalimanovska, V ;
Kalimanovska-Ostric, D .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (07) :893-898
[9]   Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control [J].
Bojanin, Dragana ;
Vekic, Jelena ;
Milenkovic, Tatjana ;
Vukovic, Rade ;
Zeljkovic, Aleksandra ;
Stefanovic, Aleksandra ;
Janac, Jelena ;
Ivanisevic, Jasmina ;
Mitrovic, Katarina ;
Miljkovic, Milica ;
Spasojevic-Kalimanovska, Vesna .
ATHEROSCLEROSIS, 2019, 280 :14-20
[10]   Effects of co-existing autoimmune diseases on serum lipids and lipoprotein subclasses profile in paediatric patients with type 1 diabetes mellitus [J].
Bojanin, Dragana ;
Milenkovic, Tatjana ;
Vekic, Jelena ;
Vukovic, Rade ;
Zeljkovic, Aleksandra ;
Janac, Jelena ;
Ivanisevic, Jasmina ;
Todorovic, Sladjana ;
Mazibrada, Ilijana ;
Spasojevic-Kalimanovska, Vesna .
CLINICAL BIOCHEMISTRY, 2018, 54 :11-17